Mortality and morbidity after transbronchial lung cryobiopsy
- Conditions
- DPLD = Diffuse parenchymal lung diseases
- Registration Number
- DRKS00026746
- Lead Sponsor
- niversitätsklinikum Krems
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Patients with radiologically proven DPLD requiring histological examination for further evaluation were chosen for inclusion in this study
Exclusion Criteria
Exclusion criteria included any possible bleeding disorders (international normalized ratio (INR) >1.3, partial thromboplastin time (PTT) above normal range, thrombocytopenia < 100.000/µl), treatment with thienopyridines, oxygen saturation below 90% after delivery of oxygen at a maximum flow rate of 2 l per minute, pre-existing severe cardiac diseases (e.g. instable angina pectoris, myocardial infarction, decompensated cardiac insufficiency) or known echocardiographically measured pulmonary hypertension with a systolic pulmonary artery pressure greater than 50 mmHg
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 90-day mortality
- Secondary Outcome Measures
Name Time Method 30-day mortality